Elisabetta Molesti
Elisabetta Molesti publishes mostly in Pediatrics, Perinatology and Child Health, Neurology and Psychiatry and Mental health, on topics such as Neonatal and fetal brain pathology, Neurogenetic and Muscular Disorders Research and Cerebral Palsy and Movement Disorders.
- World rank
- #6,826,049 of 7,710,434 ranked researchers
- Rank in Netherlands
- #103,770 of 107,149
- Works
- 19
- Citations
- 47
- Citations per work
- 2.5
What does Elisabetta Molesti research?
Elisabetta Molesti's work is mostly in Medicine (74%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1474.1%
- Medicine1474.1%
- Everything else420.3%
- Life Sciences15.6%
- 1Pediatrics, Perinatology and Child Health20% of their works
- 2Neurology20% of their works
- 3Psychiatry and Mental health15% of their works
- 4Genetics11% of their works
- 5Radiology, Nuclear Medicine and Imaging7% of their works
- 6Molecular Biology6% of their works
Research topics
- Neonatal and fetal brain pathology
- Neurogenetic and Muscular Disorders Research
- Cerebral Palsy and Movement Disorders
- Botulinum Toxin and Related Neurological Disorders
- Congenital Heart Disease Studies
- Myasthenia Gravis and Thymoma
- Infant Development and Preterm Care
- Optical Imaging and Spectroscopy Techniques
Which keywords describe Elisabetta Molesti's research?
The keywords of their largest research topics: Cerebral Palsy, Neurodevelopmental Outcomes, Epidemiology, Neuromuscular Junction, Hypoxic-Ischemic Encephalopathy, Neonatal Encephalopathy, Gross Motor Function and ICF Model.
- Thymic Tumors
- Optical Imaging
- Myasthenia Gravis
- Congenital Heart Disease
- Neurotoxins
- Spinal Muscular Atrophy
- ICF Model
- Neonatal Encephalopathy
- Neuromuscular Junction
- Neurodevelopmental Outcomes
- Cerebral Palsy
- Epidemiology
- Hypoxic-Ischemic Encephalopathy
- Gross Motor Function
- SMN1
- Botulinum Toxin
- Cardiac Surgery
- Infant Mortality
- Near-Infrared Spectroscopy
- Preterm Birth
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Cerebral Palsy142 topics
- Neurodevelopmental Outcomes143 topics
- Epidemiology92 topics
- Neuromuscular Junction92 topics
- Hypoxic-Ischemic Encephalopathy81 topic
- Neonatal Encephalopathy81 topic
- Gross Motor Function61 topic
- ICF Model61 topic
- SMN161 topic
- Spinal Muscular Atrophy61 topic
- Botulinum Toxin41 topic
- Neurotoxins41 topic
- Cardiac Surgery31 topic
- Congenital Heart Disease31 topic
- Infant Mortality31 topic
- Myasthenia Gravis31 topic
- Near-Infrared Spectroscopy31 topic
- Optical Imaging31 topic
- Preterm Birth31 topic
- Thymic Tumors31 topic
Where does Elisabetta Molesti work?
Elisabetta Molesti's main affiliation in the publication record is Florence (Netherlands), Netherlands.
How many publications and citations does Elisabetta Molesti have?
OpenAlex counts 19 works and 47 citations for Elisabetta Molesti, an h-index of 3, ranking #6,826,049 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Elisabetta Molesti. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.